Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
The UKRR PAM is being used with patients with chronic kidney disease (CKD) (stage 3b and above) as an outcome measure as part of the ‘Valuing Individuals: Transforming Participation in Chronic Kidney Disease’ work programme. This work commenced in March 2015 and will run until March 2017. The aim of using the PAM is to measure activation levels as part of wider work on person-centred care, building towards a better understanding of care pathways for long-term conditions.